Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Lung Cancer Excellence Forum

Lung Cancer
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

NGS of Cell-Free Plasma DNA Shows Value in Management of Patients With ALK+ NSCLC
Videos
NGS of Cell-Free Plasma DNA Shows Value in Management of Patients With ALK+ NSCLC
06/02/2020
David Carbone, MD, PhD, talks about the usefulness of NGS for cell-free plasma DNA in patients with ALK-positive NSCLC.
David Carbone, MD, PhD, talks about the usefulness of NGS for cell-free plasma DNA in patients with ALK-positive NSCLC.
David Carbone, MD, PhD, talks...
06/02/2020
Oncology
Videos
Anti–PD-L1 Therapy Not Recommended for Patients With NSCLC, Active Brain Metastases
06/01/2020
David Carbone, MD, PhD, comments on a study evaluating the efficacy of anti–PD1/PD-L1 monotherapy for patients with NSCLC and active brain metastases.
David Carbone, MD, PhD, comments on a study evaluating the efficacy of anti–PD1/PD-L1 monotherapy for patients with NSCLC and active brain metastases.
David Carbone, MD, PhD, comments...
06/01/2020
Oncology
Videos
The Role of Antiangiogenics in NSCLC
05/14/2020
Helen Ross, MD, discusses the role of antiangiogenics over time in treating NSCLC.
Helen Ross, MD, discusses the role of antiangiogenics over time in treating NSCLC.
Helen Ross, MD, discusses the...
05/14/2020
Oncology
Pembrolizumab Plus Chemo Continues to Improve Outcomes in NSCLC
Podcasts
Pembrolizumab Plus Chemo Continues to Improve Outcomes in NSCLC
05/04/2020
Shirish Gadgeel, MBBS, discusses updated findings from the KEYNOTE-189 clinical trial.
Shirish Gadgeel, MBBS, discusses updated findings from the KEYNOTE-189 clinical trial.
Shirish Gadgeel, MBBS, discusses...
05/04/2020
Oncology
How I Practice Now: Treating Lung Cancer and Staying Well During COVID-19
Videos
How I Practice Now: Treating Lung Cancer and Staying Well During COVID-19
04/23/2020
Kristin Higgins, MD, Winship Cancer Institute, shares how the treatment of patients with lung cancer has been impacted by the COVID-19 pandemic.
Kristin Higgins, MD, Winship Cancer Institute, shares how the treatment of patients with lung cancer has been impacted by the COVID-19 pandemic.
Kristin Higgins, MD, Winship...
04/23/2020
Oncology
Managing Oncogenic Driver Mutations in NSCLC
Videos
Managing Oncogenic Driver Mutations in NSCLC
04/16/2020
Helen Ross, MD, discusses the need to screen patients with NSCLC for driver mutations via NGS at diagnosis and after progression to help select first-, second-, and third-line targeted therapies.
Helen Ross, MD, discusses the need to screen patients with NSCLC for driver mutations via NGS at diagnosis and after progression to help select first-, second-, and third-line targeted therapies.
Helen Ross, MD, discusses the...
04/16/2020
Oncology
How I Practice Now: Lung Cancer and the COVID-19 Climate
Podcasts
How I Practice Now: Lung Cancer and the COVID-19 Climate
04/08/2020
Joshua Bauml, MD, shares first-hand insight on the management of lung cancer during the COVID-19 pandemic.
Joshua Bauml, MD, shares first-hand insight on the management of lung cancer during the COVID-19 pandemic.
Joshua Bauml, MD, shares...
04/08/2020
Oncology
The Future of Lung Cancer Screening
Videos
The Future of Lung Cancer Screening
03/03/2020
James L. Mulshine, MD, talks about what the future holds vis-a-vis advancements in lung cancer screening.
James L. Mulshine, MD, talks about what the future holds vis-a-vis advancements in lung cancer screening.
James L. Mulshine, MD, talks...
03/03/2020
Oncology
Videos
The Evolving Treatment Landscape of Mesothelioma
12/02/2019
Jessica Donington, MD, talks about old approaches and new directions in the treatment of patients with mesothelioma.
Jessica Donington, MD, talks about old approaches and new directions in the treatment of patients with mesothelioma.
Jessica Donington, MD, talks...
12/02/2019
Oncology
Videos
Approaches in the Frontline Treatment of EGFR-Positive NSCLC
11/24/2019
Edward B. Garon, MD, MS, discusses current approaches for the first-line treatment of patients with EGFR-positive NSCLC.
Edward B. Garon, MD, MS, discusses current approaches for the first-line treatment of patients with EGFR-positive NSCLC.
Edward B. Garon, MD, MS,...
11/24/2019
Oncology

Advertisement

Section Editor

cjl
Corey J. Langer, MD
Abramson Cancer Center Perelman School of Medicine, University of Pennsylvania

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement